Immuneering (IMRX) Amortizatization of Intangibles (2023 - 2026)
Immuneering's (IMRX) quarterly Amortizatization of Intangibles came in at $404723.0 in Q1 2026, up 159.86% quarter-over-quarter from $155748.0 in Q4 2025.
Immuneering (IMRX) Amortizatization of Intangibles (2023 - 2026) Analysis & Trends
Immuneering's Amortizatization of Intangibles history runs 4 years deep, the most recent figure standing at $404723.0 for Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles changed N/A year-over-year to $404723.0 in Q1 2026; TTM through Mar 2026 was $560471.0, a 474.59% increase from a year earlier, with the FY2025 full-year figure at $155748.0, down 39.91% from the prior year.
- Amortizatization of Intangibles grew to $404723.0 in Q1 2026 per IMRX's latest filing, from $155748.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $404723.0 in Q1 2026 and bottomed at $7712.0 in Q2 2024.
- The 4-year median for Amortizatization of Intangibles is $158693.5 (2024), against an average of $183723.5.
- Across the five-year window, Amortizatization of Intangibles plunged 93.29% in 2024 and jumped 179.67% in 2025, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $403631.0 in 2023, then slumped by 86.2% to $55690.0 in 2024, then jumped by 179.67% to $155748.0 in 2025, then surged by 159.86% to $404723.0 in 2026.
- Per Business Quant, the three latest IMRX Amortizatization of Intangibles figures stand at $404723.0 (Q1 2026), $155748.0 (Q4 2025), and $55690.0 (Q4 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 3.22 Mn |
| 10 | Immuneering | 279.33 Mn | 279.33 Mn | - | 404,723.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 404,723.00 |
| Mar 31, 2026 | 404,723.00 |
| Dec 31, 2025 | 155,748.00 |
| Dec 31, 2025 | 155,748.00 |
| Dec 31, 2024 | 55,690.00 |
| Dec 31, 2024 | 55,690.00 |
| Sep 30, 2024 | 34,140.00 |
| Sep 30, 2024 | 34,140.00 |
| Jun 30, 2024 | 7,712.00 |
| Jun 30, 2024 | 7,712.00 |
| Mar 31, 2024 | 161,639.00 |
| Mar 31, 2024 | 161,639.00 |
| Dec 31, 2023 | 403,631.00 |
| Dec 31, 2023 | 403,631.00 |
| Sep 30, 2023 | 311,984.00 |
| Sep 30, 2023 | 311,984.00 |
| Jun 30, 2023 | 115,004.00 |
| Jun 30, 2023 | 115,004.00 |
| Mar 31, 2023 | 186,964.00 |
| Mar 31, 2023 | 186,964.00 |